Search

June 12, 2023, New York, NY —The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKF's Innovation Fund in Klinrisk, an artificial intelligence-based medical device company. Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction and decision support.

...

A joint statement from the National Kidney Foundation and the American Society of Nephrology 

August 24, 2021 - The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) congratulate the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases for submitting its final report for publication. 

On behalf of the leadership of NKF and ASN, we are excited...

New Study Finds Significant Impact of Plant-Based Diets on CKD Patients

(December 14, 2023 – New York, NY) – A study published in this month's issue of the National Kidney Foundation American Journal of Kidney Diseases (AJKD) provides new insights into the role of diet in the management of...

Dr. Mahboob Rahman named to leadership role at Kidney Medicine an open access journal focused on clinical medicine in nephrology and hypertension 

New York, NY—May 14, 2024—The National Kidney Foundation (NKF) has named Mahboob Rahman as the new editor-in-chief of the journalKidney Medicine

Dr. Rahman is the Chief of the Division of Nephrology and Hypertension at University Hospitals Cleveland Medical Center  where he...

Long Beach, CA - May 15, 2024 - A new study to shed light on the long-term nephroprotective potential of sparsentan compared to maximally titrated irbesartan (MT-IRB) in patients with IgA nephropathy (IgAN) is set to be presented as a late-breaking presentation at the National Kidney Foundation 2024 Spring Clinical Meetings.

"Matching-Adjusted Indirect Comparisons of eGFR Slopes in the PROTECT Study With UK RaDaR IgA Nephropathy...